WEYS.NASDAQWeyco Group INC

Form 4: Weyco Group COO John Florsheim Transfers Shares to GRAT, Maintains Significant Beneficial Ownership

Sentiment:

SEC Form 4 Filing


John Florsheim, President and COO of Weyco Group Inc., reports a transfer of shares to a Grantor Retained Annuity Trust (GRAT) while maintaining significant direct and indirect beneficial ownership of company stock and stock options.

Summary

  • On October 2, 2024, John W. Florsheim, the President and COO of Weyco Group Inc. (WEYS), filed a Form 4.
  • The filing indicates a transaction where 40,250 shares of common stock were disposed of at $0 price and another 40,250 shares were acquired at $0 price, both related to a transfer to a 2022 Grantor Retained Annuity Trust (GRAT).
  • Following the reported transactions, Florsheim directly owns 429,766 shares of common stock.
  • He also indirectly owns 221,873 shares through the John Florsheim Family Trust, 94,619 shares held in a 2018 Irrevocable Trust, 307,404 shares as trustee for children, and 74,476 shares held by his wife.
  • Florsheim also holds multiple stock options with varying exercise prices and expiration dates, totaling 67,000 shares.

Sentiment

Score: 6

Explanation: The document is neutral in tone, simply reporting a transaction. The continued ownership stake is a mildly positive signal.

Positives

  • The filing indicates continued significant investment and involvement of the COO in the company through direct and indirect stock ownership.
  • The presence of stock options suggests an incentive structure aligned with the company's long-term performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of GRATs is a common estate planning technique for executives.

Stakeholder Impact

  • The transaction itself has minimal direct impact on stakeholders.
  • The continued significant ownership by the COO could be viewed positively by shareholders.

Key Dates

DateDescription
08/25/2018First stock option grant with a vesting schedule of 20% per year for 5 years, exercisable at $27.94, expiring 08/25/2027
08/23/2019Second stock option grant with a vesting schedule of 20% per year for 5 years, exercisable at $37.22, expiring 08/23/2028
08/14/2020Third stock option grant with a vesting schedule of 20% per year for 5 years, exercisable at $23.38, expiring 08/14/2029
08/26/2021Fourth stock option grant with a vesting schedule of 20% per year for 5 years, exercisable at $18, expiring 08/26/2030
08/25/2022Fifth stock option grant with a vesting schedule of 20% per year for 5 years, exercisable at $24, expiring 08/25/2031
08/25/2023Sixth stock option grant with a vesting schedule of 20% per year for 5 years, exercisable at $28.83, expiring 08/25/2032
08/25/2024Seventh stock option grant with a vesting schedule of 20% per year for 4 years, exercisable at $25.79, expiring 08/25/2033
10/02/2024Date of transaction and filing of Form 4, reporting the transfer of shares to a GRAT.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.